In the United States, the traditional version of that practice is governed by section 503A of the Federal Food, Drug, and Cosmetic Act, which is why people call it "503A compounding." The defining features of 503A are that the work is patient-specific and prescription-driven
FIGURE 4-14 Plasma concentration versus time graph for an IV drug that produces a peak plasma concentration of 100 g/ml after a single dose
Required to prevent cells from ferroptosis, a non-apoptotic cell death resulting from an iron- dependent accumulation of lipid reactive oxygen species (PubMed:24439385)
This method ensures higher absorption rates than oral supplements, which your digestive tract needs to break down
Leippe M: Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite
doi: 10.3390/antiox6030051